# Does Use of the Voy Program Improve Weight Loss Percentage and Other Health Outcomes in a Population Already Taking GLP/GIP-1RA Medication?

> **NCT06710587** · NA · NOT_YET_RECRUITING · sponsor: **Menwell Limited** · enrollment: 470 (estimated)

## Conditions studied

- Obesity
- Weight Loss

## Interventions

- **BEHAVIORAL:** Voy Program

## Key facts

- **NCT ID:** NCT06710587
- **Lead sponsor:** Menwell Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-02
- **Primary completion:** 2026-04-02
- **Final completion:** 2027-04-02
- **Target enrollment:** 470 (ESTIMATED)
- **Last updated:** 2024-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710587, "Does Use of the Voy Program Improve Weight Loss Percentage and Other Health Outcomes in a Population Already Taking GLP/GIP-1RA Medication?". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06710587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*